Loading company…
Bioclonetics Immunotherapeutics, Inc.
PrivateRaised capital from retail investors through a Regulation Crowdfunding offering on StartEngine Capital, LLC.
- SEC CIK
- 0001701251
- Founded
- 2009Source: [SEC]
- Headquarters
- Heath, TXSource: [SEC]
- Country
- United StatesSource: [SEC]
- Headcount
- 4Source: [SEC]
- Stage
$521.4KSource: [SEC]Total raised
UndisclosedSource: [SEC]Last valuation
Overview
Bioclonetics Immunotherapeutics, Inc. of Heath, TX filed a Form C with the SEC to offer securities to retail investors under Regulation Crowdfunding through the funding portal StartEngine Capital, LLC. It has filed 2 such offerings.
Funding rounds
2 rounds2 rounds · latest Crowdfunding raise (Reg CF), May 2019 · $521.4K raised
Sign in to see 2 rounds.
Sign inInvestors
No investors recorded yet for Bioclonetics Immunotherapeutics, Inc..
Add an investorPeople
LeadershipCharles S. CotropiaCEO, Principal Executive Officer and Director, Principal Financial Officer and Principal Accounting OfficerSince 2018Source: [SEC]
Acquisitions
Bioclonetics Immunotherapeutics, Inc. has no recorded acquisitions.
Add an acquisitionExits
Still private — no exit on record.
Record an exitDiversity investments
No diversity signals recorded yet for Bioclonetics Immunotherapeutics, Inc..
Add diversity data